FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer

NCT00098527 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Esophagus
Adenocarcinoma of the Stomach
Recurrent Esophageal Cancer
Recurrent Gastric Cancer

Interventions

DRUG: romidepsin
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)